Skip to main content

Table 1 Laboratory parameters in AFP-negative patients and healthy controls

From: Diagnostic value of fibrinogen to prealbumin ratio and gamma-glutamyl transpeptidase to platelet ratio in the progression of AFP-negative hepatocellular carcinoma

Characteristics

Healthy controls (N = 199)

AFP-negative CH (N = 184)

AFP-negative LC (N = 151)

AFP-NHCC (N = 180)

pa

pb

pc

Gender (male/female)

169/30

 

145/39

 

115/36

 

163/17

 

0.097

0.002

< 0.001

Age (years)

50.00

42.00–56.00

39.50

32.00–48.75

46.00

37.00–54.00

50.00

43.25–58.00

0.212

< 0.001

< 0.001

WBC (× 109/L)

6.10

5.38–6.87

6.21

5.24–7.19

5.76

3.98–7.39

6.00

5.06–7.47

0.837

0.793

0.027

Hb (g/L)

149.50

140.30–156.00

139.35

127.00–147.55

115.10

92.00–137.40

136.60

126.25–145.48

< 0.001

0.233

< 0.001

TBIL (μmol/L)

11.0

8.40–13.50

12.60

9.03–17.78

13.70

9.20–31.00

11.90

8.98–16.28

0.012

0.356

0.001

AST (U/L)

21.00

18.00–24.00

28.50

21.00–46.00

32.00

22.00–49.00

31.00

25.00–42.00

< 0.001

0.060

0.975

ALT (U/L)

20.00

16.00–25.00

32.00

20.25–77.75

27.00

18.00–45.00

33.00

25.00–46.75

< 0.001

0.667

0.007

PLT (× 109/L)

241.00

207.40–280.30

203.00

169.27–246.38

166.70

96.80–244.20

169.75

129.12–214.42

< 0.001

< 0.001

0.547

Fib (g/L)

2.84

2.54–3.21

2.69

2.24–3.23

2.30

1.78–3.03

3.21

2.73–3.95

< 0.001

< 0.001

< 0.001

PA (mg/L)

305.10

280.00–338.30

204.45

166.92–244.12

165.30

111.50–218.80

195.00

165.18–235.55

< 0.001

0.031

< 0.001

GGT (U/L)

29.00

22.00–37.00

34.55

23.18–67.80

36.00

22.00–55.00

45.00

33.25–91.50

< 0.001

< 0.001

< 0.001

FPR

9.34

7.94–10.57

13.65

11.42–15.35

14.26

10.97–17.57

16.25

12.89–21.20

< 0.001

< 0.001

< 0.001

GPR

0.12

0.08–0.16

0.18

0.11–0.36

0.23

0.13–0.39

0.31

0.18–0.56

< 0.001

< 0.001

< 0.001

  1. WBC white blood cells, Hb hemoglobin, TBIL total bilirubin, ALT alanine aminotransferase, AST aspartate amino transferase, PLT platelets, Fib fibrinogen, PA pre-albumin, GGT gamma-glutamyl transpeptidase, FPR fibrinogen to prealbumin ratio, GPR gamma-glutamyl transpeptidase to platelet ratio, AFP-NHCC alpha-fetoprotein-negative hepatocellular carcinoma, AFP alpha-fetoprotein, CH chronic hepatitis, LC liver cirrhosis
  2. aAFP-NHCC group vs healthy controls (Mann–Whitney nonparametric U test)
  3. bAFP-NHCC group vs AFP-negative CH group (Mann–Whitney nonparametric U test)
  4. cAFP-NHCC group vs AFP-negative LC group (Mann–Whitney nonparametric U test)